Search

everythinglearnresearchcommunity

for

Search:↓

DPP may help hair regrowth by improving blood vessel function under stress.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Two patients with stubborn hair loss grew hair after PDRN injections.

Apple polyphenol, especially oligomeric procyanidins, can reduce fat absorption and lower blood fat levels.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

GD-23 reduces anxiety by relying on neurosteroid production.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Purple corn extract may help reduce prostate enlargement and inflammation.

Norgalanthamine helps hair cells grow by activating certain pathways related to hair growth.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Certain drugs can cause early hair growth in mice by affecting the nerves.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

OXTR agonists may promote hair growth and be effective for treating hair loss.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Neuropeptides affect hair growth and could be used to control it.

Rebamipide may help regrow hair by activating hair follicle stem cells.

During late pregnancy in rats, hormonal changes increased certain GABAA receptors in specific brain cells.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.